Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

SAR228810: an antibody for protofibrillar amyloid β peptide designed to reduce the risk of amyloid-related imaging abnormalities (ARIA).

Pradier L, Blanchard-Brégeon V, Bohme A, Debeir T, Menager J, Benoit P, Barneoud P, Taupin V, Bertrand P, Dugay P, Cameron B, Shi Y, Naimi S, Duchesne M, Gagnaire M, Weeden T, Travaline T, Reczek D, Khiroug L, Slaoui M, Brunel P, Fukuyama H, Ravetch J, Canton T, Cohen C.

Alzheimers Res Ther. 2018 Nov 28;10(1):117. doi: 10.1186/s13195-018-0447-y.

2.

Reduction of inflammation and preservation of neurological function by anti-CD52 therapy in murine experimental autoimmune encephalomyelitis.

Turner MJ, Pang PT, Chretien N, Havari E, LaMorte MJ, Oliver J, Pande N, Masterjohn E, Carter K, Reczek D, Brondyk W, Roberts BL, Kaplan JM, Siders WM.

J Neuroimmunol. 2015 Aug 15;285:4-12. doi: 10.1016/j.jneuroim.2015.05.018. Epub 2015 May 20.

3.

Capture-stabilize approach for membrane protein SPR assays.

Chu R, Reczek D, Brondyk W.

Sci Rep. 2014 Dec 8;4:7360. doi: 10.1038/srep07360.

4.

Erythrocytes encapsulated with phenylalanine hydroxylase exhibit improved pharmacokinetics and lowered plasma phenylalanine levels in normal mice.

Yew NS, Dufour E, Przybylska M, Putelat J, Crawley C, Foster M, Gentry S, Reczek D, Kloss A, Meyzaud A, Horand F, Cheng SH, Godfrin Y.

Mol Genet Metab. 2013 Aug;109(4):339-44. doi: 10.1016/j.ymgme.2013.05.011. Epub 2013 Jul 16.

PMID:
23867524
5.

LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase.

Reczek D, Schwake M, Schröder J, Hughes H, Blanz J, Jin X, Brondyk W, Van Patten S, Edmunds T, Saftig P.

Cell. 2007 Nov 16;131(4):770-83.

6.

Effect of mannose chain length on targeting of glucocerebrosidase for enzyme replacement therapy of Gaucher disease.

Van Patten SM, Hughes H, Huff MR, Piepenhagen PA, Waire J, Qiu H, Ganesa C, Reczek D, Ward PV, Kutzko JP, Edmunds T.

Glycobiology. 2007 May;17(5):467-78. Epub 2007 Jan 24.

PMID:
17251309
7.

Chemical chaperones and permissive temperatures alter localization of Gaucher disease associated glucocerebrosidase variants.

Sawkar AR, Schmitz M, Zimmer KP, Reczek D, Edmunds T, Balch WE, Kelly JW.

ACS Chem Biol. 2006 May 23;1(4):235-51.

PMID:
17163678
8.

EPI64 regulates microvillar subdomains and structure.

Hanono A, Garbett D, Reczek D, Chambers DN, Bretscher A.

J Cell Biol. 2006 Dec 4;175(5):803-13.

9.

Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function.

Rouleau C, Roy A, St Martin T, Dufault MR, Boutin P, Liu D, Zhang M, Puorro-Radzwill K, Rulli L, Reczek D, Bagley R, Byrne A, Weber W, Roberts B, Klinger K, Brondyk W, Nacht M, Madden S, Burrier R, Shankara S, Teicher BA.

Mol Cancer Ther. 2006 Feb;5(2):219-29.

10.

Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent.

Berndt T, Craig TA, Bowe AE, Vassiliadis J, Reczek D, Finnegan R, Jan De Beur SM, Schiavi SC, Kumar R.

J Clin Invest. 2003 Sep;112(5):785-94.

15.

ERM-Merlin and EBP50 protein families in plasma membrane organization and function.

Bretscher A, Chambers D, Nguyen R, Reczek D.

Annu Rev Cell Dev Biol. 2000;16:113-43. Review.

PMID:
11031232
16.

Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain.

Pearson MA, Reczek D, Bretscher A, Karplus PA.

Cell. 2000 Apr 28;101(3):259-70.

17.

A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2-adrenergic receptor.

Cao TT, Deacon HW, Reczek D, Bretscher A, von Zastrow M.

Nature. 1999 Sep 16;401(6750):286-90.

PMID:
10499588
18.

C-terminal threonine phosphorylation activates ERM proteins to link the cell's cortical lipid bilayer to the cytoskeleton.

Simons PC, Pietromonaco SF, Reczek D, Bretscher A, Elias L.

Biochem Biophys Res Commun. 1998 Dec 30;253(3):561-5.

PMID:
9918767
19.

An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton.

Short DB, Trotter KW, Reczek D, Kreda SM, Bretscher A, Boucher RC, Stutts MJ, Milgram SL.

J Biol Chem. 1998 Jul 31;273(31):19797-801.

21.
22.
23.

Modification of high-heeled shoes to decrease pronation during gait.

Phillips RD, Reczek DM, Fountain D, Renner J, Park DB.

J Am Podiatr Med Assoc. 1991 Apr;81(4):215-9.

PMID:
1875295

Supplemental Content

Loading ...
Support Center